Mehmet Ali Gul
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Mehmet Ali Gul has a total of 116 co-authors. Here are the top co-authors by number of shared publications:
- Mustafa Çapraz
Department of Internal Medicine, Amasya University, Sabuncuoğlu Şerefeddin Training and Research Hospital, Amasya, Turkey
9 shared publications - Duygu Tozcu
Department of Physiology, Faculty of Medicine, Amasya University, Amasya 05100, Türkiye
8 shared publications - Nurinnisa Öztürk
Atatürk Üniversitesi Tıp Fakültesi, Biyokimya Anabilim Dalı, Erzurum
6 shared publications Ebubekir Bakan
Department of Medical Biochemistry, School of Medicine, Ataturk University, Erzurum, Turkey
4 shared publications- Nezahat Kurt
Department of Biochemistry, Faculty of Medicine, Erzincan Binali Yıldırım University, Erzincan 24100, Türkiye
4 shared publications - Akin Tekcan
Amasya University, Turkey
3 shared publications
Latest Publications
- Open Access
- 21 June 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (12) , 4807
Reduced Aqueous Humor TGF-β2 Levels in Diabetic Cataract: A Comparative Analysis with NF-κB
Background/Objectives: Type 2 diabetes may impair anterior segment immune regulation. Because transforming growth factor-β2 maintains ocular immune privilege, while nuclear factor-κB is linked to inflammatory activation, we compared their aqueous humor levels in cataract patients with and without diabetes. Methods: In this prospective cross-sectional study, aqueous humor samples were collected from 90 patients (30 diabetic, 60 non-diabetic) via anterior chamber needle aspiration at the commencement of routine phacoemulsification, prior to viscoelastic injection, without additional intervention. Transforming growth factor-β2 and nuclear factor-κB levels were then measured using enzyme-linked immunosorbent assay (ELISA). Between-group comparisons and ROC curve analyses were performed to evaluate differences in biomarker levels and their discriminative ability in distinguishing diabetic status. Covariate-adjusted analysis (ANCOVA) was additionally performed. Results: Transforming growth factor-β2 levels were significantly lower in the diabetic group (p < 0.001), while nuclear factor-κB levels showed no significant difference (p = 0.285). The between-group difference in transforming growth factor-β2 remained significant after adjustment for cataract grade and hypertension duration (F(1,86) = 17.901, p < 0.001, partial η2 = 0.172; Cohen’s d = 0.94). Transforming growth factor-β2 demonstrated high specificity (100%) but limited sensitivity (45%) for identifying diabetic status at a cut-off of <449.25 ng/L; however, given the small sample size and exploratory nature of the study, this specificity value should be interpreted with caution and requires validation in larger cohorts. Conclusions: Lower aqueous humor TGF-β2 levels in diabetic cataract patients, independent of cataract severity and hypertension duration, suggest that TGF-β2 suppression may represent an earlier molecular event in anterior segment immune dysregulation preceding overt inflammatory activation. While TGF-β2 shows exploratory biomarker potential, validation in larger, prospective, mechanistic studies is required before clinical application.
- 21 June 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (12) , 4807
Open AccessReduced Aqueous Humor TGF-β2 Levels in Diabetic Cataract: A Comparative Analysis with NF-κB
Background/Objectives: Type 2 diabetes may impair anterior segment immune regulation. Because transforming growth factor-β2 maintains ocular immune privilege, while nuclear factor-κB is linked to inflammatory activation, we compared their aqueous humor levels in cataract patients with and without diabetes. Methods: In this prospective cross-sectional study, aqueous humor samples were collected from 90 patients (30 diabetic, 60 non-diabetic) via anterior chamber needle aspiration at the commencement of routine phacoemulsification, prior to viscoelastic injection, without additional intervention. Transforming growth factor-β2 and nuclear factor-κB levels were then measured using enzyme-linked immunosorbent assay (ELISA). Between-group comparisons and ROC curve analyses were performed to evaluate differences in biomarker levels and their discriminative ability in distinguishing diabetic status. Covariate-adjusted analysis (ANCOVA) was additionally performed. Results: Transforming growth factor-β2 levels were significantly lower in the diabetic group (p < 0.001), while nuclear factor-κB levels showed no significant difference (p = 0.285). The between-group difference in transforming growth factor-β2 remained significant after adjustment for cataract grade and hypertension duration (F(1,86) = 17.901, p < 0.001, partial η2 = 0.172; Cohen’s d = 0.94). Transforming growth factor-β2 demonstrated high specificity (100%) but limited sensitivity (45%) for identifying diabetic status at a cut-off of <449.25 ng/L; however, given the small sample size and exploratory nature of the study, this specificity value should be interpreted with caution and requires validation in larger cohorts. Conclusions: Lower aqueous humor TGF-β2 levels in diabetic cataract patients, independent of cataract severity and hypertension duration, suggest that TGF-β2 suppression may represent an earlier molecular event in anterior segment immune dysregulation preceding overt inflammatory activation. While TGF-β2 shows exploratory biomarker potential, validation in larger, prospective, mechanistic studies is required before clinical application.
- Open Access
- 26 October 2025
- Published by MDPI AG in Biomedicines
- Vol. 13 (11) , 2619
Investigation of Serum Visfatin and Chemerin Levels in Type 2 Diabetes and Obesity Patients: Their Potential Role as Clinical and Biomarkers
Background/Objectives: The global prevalence of obesity and type 2 diabetes mellitus (T2DM) has been steadily increasing, and these interrelated disorders share common pathophysiological mechanisms, including altered levels of adipokines secreted from adipose tissue. Among these, chemerin and visfatin have been suggested as potential biomarkers for obesity-related metabolic dysfunction. This study aimed to evaluate the relationship between serum chemerin and visfatin levels and obesity in patients with T2DM. Methods: The study included 74 obese T2DM patients, 60 non-obese T2DM patients, and 36 healthy controls. Serum chemerin and visfatin levels were measured using an enzyme-linked immunosorbent assay (ELISA). Clinical parameters including HbA1c, fasting plasma glucose, insulin, and Homeostatic Model Assessment of Insulin Resistance (HOMA-IR) were assessed. Between-group comparisons were performed using appropriate parametric or non-parametric tests with Bonferroni correction for multiple comparisons. ROC curve analysis was applied to evaluate the diagnostic performance of visfatin. Results: Serum visfatin levels were significantly higher in the T2DM (33.00 ± 20.61) groups compared to controls (30.25 ± 26.40; p = 0.01), while chemerin levels showed no significant difference. HbA1c and glucose levels were elevated in both diabetic groups, whereas insulin and HOMA-IR were significantly higher only in the obese T2DM group. Receiver operating characteristic (ROC) analysis revealed limited diagnostic accuracy of visfatin (AUC < 0.70). Conclusions: Visfatin levels were modestly higher in obese T2DM patients, while chemerin did not differ significantly among groups. However, the diagnostic performance of visfatin was limited (AUC < 0.70), and these findings should be regarded as exploratory. Larger, well-controlled studies are required to clarify whether visfatin or chemerin could have any clinical utility as part of multi-marker approaches.
- 26 October 2025
- Published by MDPI AG in Biomedicines
- Vol. 13 (11) , 2619
Open AccessInvestigation of Serum Visfatin and Chemerin Levels in Type 2 Diabetes and Obesity Patients: Their Potential Role as Clinical and Biomarkers
Background/Objectives: The global prevalence of obesity and type 2 diabetes mellitus (T2DM) has been steadily increasing, and these interrelated disorders share common pathophysiological mechanisms, including altered levels of adipokines secreted from adipose tissue. Among these, chemerin and visfatin have been suggested as potential biomarkers for obesity-related metabolic dysfunction. This study aimed to evaluate the relationship between serum chemerin and visfatin levels and obesity in patients with T2DM. Methods: The study included 74 obese T2DM patients, 60 non-obese T2DM patients, and 36 healthy controls. Serum chemerin and visfatin levels were measured using an enzyme-linked immunosorbent assay (ELISA). Clinical parameters including HbA1c, fasting plasma glucose, insulin, and Homeostatic Model Assessment of Insulin Resistance (HOMA-IR) were assessed. Between-group comparisons were performed using appropriate parametric or non-parametric tests with Bonferroni correction for multiple comparisons. ROC curve analysis was applied to evaluate the diagnostic performance of visfatin. Results: Serum visfatin levels were significantly higher in the T2DM (33.00 ± 20.61) groups compared to controls (30.25 ± 26.40; p = 0.01), while chemerin levels showed no significant difference. HbA1c and glucose levels were elevated in both diabetic groups, whereas insulin and HOMA-IR were significantly higher only in the obese T2DM group. Receiver operating characteristic (ROC) analysis revealed limited diagnostic accuracy of visfatin (AUC < 0.70). Conclusions: Visfatin levels were modestly higher in obese T2DM patients, while chemerin did not differ significantly among groups. However, the diagnostic performance of visfatin was limited (AUC < 0.70), and these findings should be regarded as exploratory. Larger, well-controlled studies are required to clarify whether visfatin or chemerin could have any clinical utility as part of multi-marker approaches.
- 22 October 2025
- Published by Kocaeli University in Acta Medica Nicomedia
- Vol. 8 (3) , 295-300
SERUM ASPROSİN DÜZEYLERİ İLE NONPROLİFERATİF VE PROLİFERATİF DİYABETİK RETİNOPATİ ARASINDA BİR İLİŞKİ VAR MIDIR?
Amaç: Çalışmamızdaki amacımız serum asprosin seviyelerinin diyabetik retinopati (DR) patogenezindeki rolünü araştırmak ve diyabetin farklı evreleri için olası farklılıkları ortaya koymaktı. Yöntem: Bu prospektif çalışmaya Tip 2 diyabetes mellitus (T2DM)’lu, 32 nonproliferatif diyabetik retinopati (NPDR), 28 proliferatif diyabetik retinopati (PDR) hastası ile 30 sağlıklı birey dahil edildi. Tüm katılımcıların antropometrik ölçümleri yapıldı. Biyokimyasal parametreler değerlendirildi. Serum asprosin seviyeleri enzyme-linked immunosorbent assay (ELISA) yöntemi kullanılarak analiz edildi. Bulgular: Açlık kan glukozu (AKG), insülin, insülin direncinin homeostaz modeliyle değerlendirmesi (HOMA-IR), hemoglobin A1c (HbA1c), trigliserid ve vücut kitle indeksi (VKİ) değerleri; DR gruplarında kontrol grubuna göre istatistiksel açıdan anlamlı derecede daha yüksek bulundu (p
- 22 October 2025
- Published by Kocaeli University in Acta Medica Nicomedia
- Vol. 8 (3) , 295-300
SERUM ASPROSİN DÜZEYLERİ İLE NONPROLİFERATİF VE PROLİFERATİF DİYABETİK RETİNOPATİ ARASINDA BİR İLİŞKİ VAR MIDIR?
Amaç: Çalışmamızdaki amacımız serum asprosin seviyelerinin diyabetik retinopati (DR) patogenezindeki rolünü araştırmak ve diyabetin farklı evreleri için olası farklılıkları ortaya koymaktı. Yöntem: Bu prospektif çalışmaya Tip 2 diyabetes mellitus (T2DM)’lu, 32 nonproliferatif diyabetik retinopati (NPDR), 28 proliferatif diyabetik retinopati (PDR) hastası ile 30 sağlıklı birey dahil edildi. Tüm katılımcıların antropometrik ölçümleri yapıldı. Biyokimyasal parametreler değerlendirildi. Serum asprosin seviyeleri enzyme-linked immunosorbent assay (ELISA) yöntemi kullanılarak analiz edildi. Bulgular: Açlık kan glukozu (AKG), insülin, insülin direncinin homeostaz modeliyle değerlendirmesi (HOMA-IR), hemoglobin A1c (HbA1c), trigliserid ve vücut kitle indeksi (VKİ) değerleri; DR gruplarında kontrol grubuna göre istatistiksel açıdan anlamlı derecede daha yüksek bulundu (p
- Open Access
- 29 August 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (17) , 8436
The Role of ADAM9 and MMP9 in Diabetic Retinopathy: Insights from Ocular Parameters
The focus in this study was to investigate the proteolytic functions of matrix metalloproteinases (MMPs) and a disintegrin and metalloprotease (ADAM) proteins in the progression of diabetic retinopathy (DR) and to evaluate their potential as therapeutic targets for eye diseases. This study involved three groups: non-proliferative diabetic retinopathy patients (NPDR) (n = 27), proliferative diabetic retinopathy patients (PDR) (n = 32), and a control group of 30 healthy individuals. Serum levels of ADAM9 and MMP9 were measured across these groups for comparative analysis. Serum ADAM9 levels were significantly lower in the NPDR and PDR groups than in the control group (p = 0.031, p < 0.001). Although ADAM9 levels were lower in the PDR group than in the NPDR group, this difference was not significant (p = 0.142). Serum MMP9 levels in the PDR group were significantly lower than those in both the control and NPDR groups (p = 0.039, p = 0.013). The findings of this study indicate that ADAM9, MMP9, and left-eye ocular parameters may have potential value in the assessment of DR. The notable variation in the MMP9 marker in the proliferative stage, as opposed to its stability in the non-proliferative stage, suggests a distinct role in retinopathy staging. This underscores the specific importance of MMP9 in the proliferative stage.
- 29 August 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (17) , 8436
Open AccessThe Role of ADAM9 and MMP9 in Diabetic Retinopathy: Insights from Ocular Parameters
The focus in this study was to investigate the proteolytic functions of matrix metalloproteinases (MMPs) and a disintegrin and metalloprotease (ADAM) proteins in the progression of diabetic retinopathy (DR) and to evaluate their potential as therapeutic targets for eye diseases. This study involved three groups: non-proliferative diabetic retinopathy patients (NPDR) (n = 27), proliferative diabetic retinopathy patients (PDR) (n = 32), and a control group of 30 healthy individuals. Serum levels of ADAM9 and MMP9 were measured across these groups for comparative analysis. Serum ADAM9 levels were significantly lower in the NPDR and PDR groups than in the control group (p = 0.031, p < 0.001). Although ADAM9 levels were lower in the PDR group than in the NPDR group, this difference was not significant (p = 0.142). Serum MMP9 levels in the PDR group were significantly lower than those in both the control and NPDR groups (p = 0.039, p = 0.013). The findings of this study indicate that ADAM9, MMP9, and left-eye ocular parameters may have potential value in the assessment of DR. The notable variation in the MMP9 marker in the proliferative stage, as opposed to its stability in the non-proliferative stage, suggests a distinct role in retinopathy staging. This underscores the specific importance of MMP9 in the proliferative stage.
- Open Access
- 19 June 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (12) , 5906
Comparison Bioinformatic Analysis of Extracellular Vesicles-Related Genes and MicroRNAs in Breast Cancer
Breast cancer (BC) remains a leading cause of cancer-related mortality in women, with treatment challenges due to the lack of targeted therapies. Extracellular vesicles (EVs) play a crucial role in BC progression by carrying bioactive molecules. This study analyzed EV-associated molecules (ENPEP, TIMP1, CD36, MARCKS, DAB2, CXCL14, miR-181b-5p, miR-222-3p) using bioinformatics tools. We used GEPIA2; Human Protein Atlas (HPA) 24.0; bc-GenExMiner v5.1; UALCAN 2022; Kaplan–Meier plotter 2025; ENCORI database v2.0; Enrichr-KG web tool 2021; Cancer Hallmark Enrichment tool 2025; Tumor, Normal, and Metastatic (TNM) plot database 2025; MicroRNA Target Prediction Database 6.0; TargetScan 8.0; and STRING database 12.0. CD36, DAB2, and CXCL14 were significantly downregulated, while TIMP1 was upregulated in BC tissues (p < 0.05). CD36, CXCL14, and DAB2 were predominantly low in triple-negative and basal-like subtypes, whereas TIMP1 was higher in HER2+, ER+, and PR+ tumors (p < 0.01). These changes correlated with promoter methylation patterns. Higher TIMP1, DAB2, and CXCL14 levels were associated with improved overall survival (p < 0.05). miR-222-3p was downregulated and positively correlated with TIMP1 and DAB2, while miR-181b-5p was upregulated and negatively correlated with CXCL14. TNM analysis confirmed these expression changes. Functional enrichment linked these molecules to key cancer hallmarks, including proliferation and angiogenesis. CD36, DAB2, CXCL14, TIMP1, miR-222-3p, and miR-181b-5p may serve as biomarkers for BC pathogenesis and potential therapeutic targets. Further studies are needed to validate these findings.
- 19 June 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (12) , 5906
Open AccessComparison Bioinformatic Analysis of Extracellular Vesicles-Related Genes and MicroRNAs in Breast Cancer
Breast cancer (BC) remains a leading cause of cancer-related mortality in women, with treatment challenges due to the lack of targeted therapies. Extracellular vesicles (EVs) play a crucial role in BC progression by carrying bioactive molecules. This study analyzed EV-associated molecules (ENPEP, TIMP1, CD36, MARCKS, DAB2, CXCL14, miR-181b-5p, miR-222-3p) using bioinformatics tools. We used GEPIA2; Human Protein Atlas (HPA) 24.0; bc-GenExMiner v5.1; UALCAN 2022; Kaplan–Meier plotter 2025; ENCORI database v2.0; Enrichr-KG web tool 2021; Cancer Hallmark Enrichment tool 2025; Tumor, Normal, and Metastatic (TNM) plot database 2025; MicroRNA Target Prediction Database 6.0; TargetScan 8.0; and STRING database 12.0. CD36, DAB2, and CXCL14 were significantly downregulated, while TIMP1 was upregulated in BC tissues (p < 0.05). CD36, CXCL14, and DAB2 were predominantly low in triple-negative and basal-like subtypes, whereas TIMP1 was higher in HER2+, ER+, and PR+ tumors (p < 0.01). These changes correlated with promoter methylation patterns. Higher TIMP1, DAB2, and CXCL14 levels were associated with improved overall survival (p < 0.05). miR-222-3p was downregulated and positively correlated with TIMP1 and DAB2, while miR-181b-5p was upregulated and negatively correlated with CXCL14. TNM analysis confirmed these expression changes. Functional enrichment linked these molecules to key cancer hallmarks, including proliferation and angiogenesis. CD36, DAB2, CXCL14, TIMP1, miR-222-3p, and miR-181b-5p may serve as biomarkers for BC pathogenesis and potential therapeutic targets. Further studies are needed to validate these findings.
- Open Access
- 20 March 2025
- Published by Adnan Menderes University in Meandros Medical and Dental Journal
- Vol. 26 (1) , 129-135
Investigation of Inflammation Rates (Neutrophil/Lymphocyte) and Hemogram Results in the Stages of Non-Alcoholic Fatty Liver Disease
Introducton: Non-alcoholic fatty liver disease (NAFLD) is a chronic condition characterized by excessive fat accumulation in the liver accompanied by inflammation. This study aims to know the diagnostic value of NLR in stages of NAFLD Methods: A retrospective case-control study was conducted, including 49 NAFLD patients with NAFLD Grade 1, 48 with NAFLD Grade 2, 52 with NAFLD Grade 3, and 103 healthy control (HC) individuals. Neutrophil/Lymphocyte ratios as well as RBC, HGB, HCT, MCHC, MPV, WBC, MCV, MCH, PLT, RDW-SD, RDW-CV, PDW, PCT, NEUT#, LYMPH%, NLR, MONO%, EO%, BASO% values were examined. Results: As the disease stages progressed (G3), a significant decrease (p=0.005*) in MPV values and a significant increase (p0.05), MCH (p>0.05), PDW (p>0.05), PCT (p>0.05), MONO (p>0.05) and EO (p>0.05) parameters. Conclusion: MPV and NLR may be considered as effective biomarkers for monitoring the progression of NAFLD and evaluating the inflammatory status of patients.
- 20 March 2025
- Published by Adnan Menderes University in Meandros Medical and Dental Journal
- Vol. 26 (1) , 129-135
Open AccessInvestigation of Inflammation Rates (Neutrophil/Lymphocyte) and Hemogram Results in the Stages of Non-Alcoholic Fatty Liver Disease
Introducton: Non-alcoholic fatty liver disease (NAFLD) is a chronic condition characterized by excessive fat accumulation in the liver accompanied by inflammation. This study aims to know the diagnostic value of NLR in stages of NAFLD Methods: A retrospective case-control study was conducted, including 49 NAFLD patients with NAFLD Grade 1, 48 with NAFLD Grade 2, 52 with NAFLD Grade 3, and 103 healthy control (HC) individuals. Neutrophil/Lymphocyte ratios as well as RBC, HGB, HCT, MCHC, MPV, WBC, MCV, MCH, PLT, RDW-SD, RDW-CV, PDW, PCT, NEUT#, LYMPH%, NLR, MONO%, EO%, BASO% values were examined. Results: As the disease stages progressed (G3), a significant decrease (p=0.005*) in MPV values and a significant increase (p0.05), MCH (p>0.05), PDW (p>0.05), PCT (p>0.05), MONO (p>0.05) and EO (p>0.05) parameters. Conclusion: MPV and NLR may be considered as effective biomarkers for monitoring the progression of NAFLD and evaluating the inflammatory status of patients.
- Open Access
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 71 (1) , e20241191
Investigation of the rs7041 variable of vitamin D-connector protein gene relation with pancreatic involvement in patients with coronavirus disease 2019
OBJECTIVE: This study aims to examine whether the presence of mutation exists in the vitamin D-connector protein gene rs7041 variant of the pancreatitis table for patients diagnosed with coronavirus disease 2019.
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 71 (1) , e20241191
Open AccessInvestigation of the rs7041 variable of vitamin D-connector protein gene relation with pancreatic involvement in patients with coronavirus disease 2019
OBJECTIVE: This study aims to examine whether the presence of mutation exists in the vitamin D-connector protein gene rs7041 variant of the pancreatitis table for patients diagnosed with coronavirus disease 2019.
- Open Access
- 1 July 2024
- Published by Galenos Yayinevi in European Journal of Breast Health
- Vol. 20 (3) , 178-184
Bioinformatic Investigation of Genetic Changes in Paraoxonase Genes in Breast Cancer and Breast Cancer Subtypes
Bioinformatic Investigation of Genetic Changes in Paraoxonase Genes in Breast Cancer and Breast Cancer Subtypes - European Journal of Breast Health
- 1 July 2024
- Published by Galenos Yayinevi in European Journal of Breast Health
- Vol. 20 (3) , 178-184
Open AccessBioinformatic Investigation of Genetic Changes in Paraoxonase Genes in Breast Cancer and Breast Cancer Subtypes
Bioinformatic Investigation of Genetic Changes in Paraoxonase Genes in Breast Cancer and Breast Cancer Subtypes - European Journal of Breast Health
- Open Access
- 21 March 2024
- Published by Wroclaw Medical University in Advances in Clinical and Experimental Medicine
- Vol. 33 (7) , 691-698
C-terminal cross-linking telopeptide levels in COVID-19 patients: A prospective case-control study
Coronavirus disease 19 (COVID-19) is a viral infection mediated by coronavirus-2 that causes severe acute respiratory syndrome (SARS-CoV-2). The disease may affect biochemical parameters and electrolytes. C-terminal cross-linking telopeptide (CTX-I) is released during mature bone resorption and is a biomarker for predicting bone resorption. As the pandemic progressed, understanding the effects of COVID-19 disease remained critical. Inflammatory responses triggered by the virus can result in a bone metabolism regulation imbalance. As such, this study aimed to analyze serum levels of CTX-I, calcium (CA), phosphorus (P), magnesium (Mg), C-reactive protein (CRP), and alkaline phosphatase (ALP) in COVID-19 patients to investigate the relationship between bone resorption and the disease. The study included 56 individuals with COVID-19 (divided into mild, moderate and severe subgroups depending on disease severity) and 25 healthy adults as a control group. Serum CTX-I concentrations were measured with enzyme-linked immunosorbent assay (ELISA). In addition, CRP, Ca, Mg, P, and ALP levels were measured using an automated clinical chemistry analyzer. Serum CTX-I levels were significantly higher in COVID-19 patients than in the control group (p < 0.05). Furthermore, a positive weak relationship was detected between CRP and CTX-I (r = 0.303, p < 0.05). Increased serum CTX-I levels in the patient group caused COVID-19-driven bone degradation, though serum CTX-I levels did not differ according to disease severity.
- 21 March 2024
- Published by Wroclaw Medical University in Advances in Clinical and Experimental Medicine
- Vol. 33 (7) , 691-698
Open AccessC-terminal cross-linking telopeptide levels in COVID-19 patients: A prospective case-control study
Coronavirus disease 19 (COVID-19) is a viral infection mediated by coronavirus-2 that causes severe acute respiratory syndrome (SARS-CoV-2). The disease may affect biochemical parameters and electrolytes. C-terminal cross-linking telopeptide (CTX-I) is released during mature bone resorption and is a biomarker for predicting bone resorption. As the pandemic progressed, understanding the effects of COVID-19 disease remained critical. Inflammatory responses triggered by the virus can result in a bone metabolism regulation imbalance. As such, this study aimed to analyze serum levels of CTX-I, calcium (CA), phosphorus (P), magnesium (Mg), C-reactive protein (CRP), and alkaline phosphatase (ALP) in COVID-19 patients to investigate the relationship between bone resorption and the disease. The study included 56 individuals with COVID-19 (divided into mild, moderate and severe subgroups depending on disease severity) and 25 healthy adults as a control group. Serum CTX-I concentrations were measured with enzyme-linked immunosorbent assay (ELISA). In addition, CRP, Ca, Mg, P, and ALP levels were measured using an automated clinical chemistry analyzer. Serum CTX-I levels were significantly higher in COVID-19 patients than in the control group (p < 0.05). Furthermore, a positive weak relationship was detected between CRP and CTX-I (r = 0.303, p < 0.05). Increased serum CTX-I levels in the patient group caused COVID-19-driven bone degradation, though serum CTX-I levels did not differ according to disease severity.
- Open Access
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 70 (3) , e20231000
Serum adiponectin and peroxisome proliferator-activated receptors-γ levels in obese patients with and without prediabetes
Obesity is an increasingly prevalent global health problem, which is generally caused by the increase in body fat mass above normal and observed in all societies. If the blood glucose level is higher than normal but not high enough to diagnose diabetes, this condition is defined as prediabetes. Adiponectin increases fatty acid oxidation and insulin sensitivity and is closely associated with obesity. One of the nuclear receptor superfamily member peroxisome proliferator-activated receptors is shown to have an important role in various metabolic reactions. This study aimed to investigate the serum levels of adiponectin and peroxisome proliferator-activated receptors-gamma parameters, which are closely related to adipose tissue, energy metabolism, and insulin sensitivity, in obese patients with and without prediabetes.
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 70 (3) , e20231000
Open AccessSerum adiponectin and peroxisome proliferator-activated receptors-γ levels in obese patients with and without prediabetes
Obesity is an increasingly prevalent global health problem, which is generally caused by the increase in body fat mass above normal and observed in all societies. If the blood glucose level is higher than normal but not high enough to diagnose diabetes, this condition is defined as prediabetes. Adiponectin increases fatty acid oxidation and insulin sensitivity and is closely associated with obesity. One of the nuclear receptor superfamily member peroxisome proliferator-activated receptors is shown to have an important role in various metabolic reactions. This study aimed to investigate the serum levels of adiponectin and peroxisome proliferator-activated receptors-gamma parameters, which are closely related to adipose tissue, energy metabolism, and insulin sensitivity, in obese patients with and without prediabetes.